HealthEquity (NASDAQ:HQY) Price Target Raised to $125.00

HealthEquity (NASDAQ:HQY) had its price target raised by research analysts at Wells Fargo & Company from $110.00 to $125.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 15.96% from the stock’s previous close.

A number of other equities research analysts have also weighed in on the stock. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. Bank of America boosted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Finally, JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $113.54.

HealthEquity Trading Down 1.5 %

NASDAQ:HQY opened at $107.80 on Wednesday. The firm has a market capitalization of $9.34 billion, a P/E ratio of 96.90, a P/E/G ratio of 1.60 and a beta of 0.55. The company has a fifty day moving average of $104.31 and a 200 day moving average of $92.89. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the company posted $0.40 EPS. On average, research analysts predict that HealthEquity will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock worth $3,895,788 over the last three months. 2.20% of the stock is currently owned by company insiders.

Institutional Trading of HealthEquity

Institutional investors and hedge funds have recently bought and sold shares of the stock. Private Advisor Group LLC purchased a new stake in shares of HealthEquity in the third quarter worth about $208,000. Wealth Enhancement Advisory Services LLC boosted its position in shares of HealthEquity by 18.8% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock valued at $299,000 after acquiring an additional 578 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in shares of HealthEquity by 7.2% in the third quarter. State of Alaska Department of Revenue now owns 10,146 shares of the company’s stock valued at $830,000 after purchasing an additional 685 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in HealthEquity by 19.8% during the third quarter. Nisa Investment Advisors LLC now owns 3,420 shares of the company’s stock valued at $280,000 after purchasing an additional 566 shares during the last quarter. Finally, New York State Teachers Retirement System raised its position in shares of HealthEquity by 1.4% during the 3rd quarter. New York State Teachers Retirement System now owns 83,997 shares of the company’s stock valued at $6,875,000 after buying an additional 1,146 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.